Moderna slashes 2025 sales forecast, shares sink
Portfolio Pulse from
Moderna Inc's shares dropped nearly 20% after the company announced a lower-than-expected sales forecast for fiscal 2024, projecting $3 billion to $3.1 billion in sales compared to the expected $3.3 billion.
January 13, 2025 | 7:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Moderna's shares fell by nearly 20% after announcing a 2024 sales forecast of $3 billion to $3.1 billion, which is below the expected $3.3 billion.
The significant drop in Moderna's stock price is directly linked to the company's announcement of a lower-than-expected sales forecast for 2024. The market reacted negatively to the news, as the forecasted sales of $3 billion to $3.1 billion fell short of the $3.3 billion consensus, indicating potential challenges in revenue growth.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100